Cidara Therapeutics, Inc. Skyrocketed
Wed, Jan 25, 2023 at 06:59 PM
Cidara Therapeutics, Inc. (CDTX:NASDAQ) soared at $1.28, a gain of 37.9%. The stock got featured on our News Catalysts scanner on Wed, Jan 25, 2023 at 01:05 PM in the 'BIOTECH' category. From Wed, Jan 11, 2023, the stock recorded 66.67% Up Days and 70.00% Green Days
The stock spiked on Tue, Jan 17, 2023 at $1.6 with a volume of 1M+.
About Cidara Therapeutics, Inc. (CDTX:NASDAQ)
Cidara Therapeutics Inc mainly develops anti-infective drugs in the United States. It attends to serious fungal infections through its drug candidates and proprietary immunotherapy technology platform, CloudbreakTM.
Top 10 Gainers:
- Schmitt Industries, Inc. (SMIT:NASDAQ), 240.05%
- Minerva Surgical Inc. (UTRS:NASDAQ), 72.37%
- Alvarium Tiedemann Holdings Inc. (ALTI:NASDAQ), 65.41%
- Aridis Pharmaceuticals, Inc. (ARDS:NASDAQ), 46.43%
- Sonoma Pharmaceuticals, Inc. (SNOA:NASDAQ), 40.83%
- Cidara Therapeutics, Inc. (CDTX:NASDAQ), 37.92%
- iPower Inc. (IPW:NASDAQ), 36.35%
- Xilio Therapeutics Inc. (XLO:NASDAQ), 35.86%
- 180 Life Sciences Corp. (ATNF:NASDAQ), 33.75%
- eHealth, Inc. (EHTH:NASDAQ), 32.29%